- Gene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
Sanaz Naghizadeh et al, 2019, Current Medicinal Chemistry CrossRef - Identification of MX2 as a Novel Prognostic Biomarker for Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
Yuang Wei et al, 2021, Frontiers in Genetics CrossRef - Targeting the PI3K/AKT signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Dima A. Sabbah et al, 2024, Expert Opinion on Therapeutic Patents CrossRef - Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
Taek-In Oh et al, 2017, Molecules CrossRef - Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer
Om Elez Bouhniz et al, 2024, Journal of Chemotherapy CrossRef - PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells
ZAHRA NASRPOUR NAVAEI et al, 2021, Oncology Research CrossRef - MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer
Wei-Zhong Sheng et al, 2016, World Journal of Gastroenterology CrossRef - Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
Jiehan Li et al, 2022, Frontiers in Cell and Developmental Biology CrossRef - Knockdown ofAKT3(PKBγ) andPI3KCASuppresses Cell Viability and Proliferation and Induces the Apoptosis of Glioblastoma Multiforme T98G Cells
Monika Paul-Samojedny et al, 2014, BioMed Research International CrossRef - Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway
Jun Xu et al, 2017, Bioscience Reports CrossRef - Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
Tomas Koltai et al, 2022, Cancers CrossRef - Computational modeling in melanoma for novel drug discovery
Marzio Pennisi et al, 2016, Expert Opinion on Drug Discovery CrossRef